Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

Market Cap	45.73B
Revenue (ttm)	4.44B
Net Income (ttm)	1.85B
Shares Out	785.72M
EPS (ttm)	2.36
PE Ratio	24.71
Forward PE	21.44
Dividend	1.00 (1.71%)
Ex-Dividend Date	May 15, 2024

Volume	3,009,038
Average Volume	3,028,326
Open	59.90
Previous Close	58.51
Day's Range	57.64 - 59.90
52-Week Range	57.25 - 97.20
Beta	-0.42
RSI	33.05
Earnings Date	Apr 18, 2025

About SHE:300832

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,627
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300832

Financial Performance

In 2023, SHE:300832's revenue was 3.93 billion, an increase of 28.97% compared to the previous year's 3.05 billion. Earnings were 1.65 billion, an increase of 24.53%.